Tri Nofita Wulandari
Universitas Duta Bangsa Surakarta

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Hubungan Medication Beliefs dengan Kualitas Hidup pada Pasien Hipertensi di Puskesmas Ngemplak Boyolali Tri Nofita Wulandari; Niken Luthfiyanti; Rahmat Hidayat
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 4 No. 6 (2026): November: OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v4i6.2627

Abstract

Hypertension is a chronic condition requiring long-term treatment to control blood pressure and prevent complications. Patients’ perceptions of the necessity of their medication and concerns about its use, collectively known as medication beliefs, may influence their treatment experience and quality of life. This study aimed to determine the relationship between medication beliefs and quality of life among hypertensive patients treated at Ngemplak Public Health Center, Boyolali, in 2026. A cross-sectional design was applied to 92 hypertensive patients who met the inclusion criteria. Medication beliefs were assessed using the Beliefs about Medicines Questionnaire (BMQ), while quality of life was measured using the WHOQOL-BREF. The relationship between the two variables was analyzed using the Chi-Square test. Positive medication beliefs were found in 52 respondents (56.5%), followed by negative beliefs in 29 respondents (31.5%) and neutral beliefs in 11 respondents (12.0%). Regarding overall quality of life, 77 respondents (83.7%) had high quality of life and 15 respondents (16.3%) had moderate quality of life; none had low quality of life. The Chi-Square test showed no statistically significant relationship between medication beliefs and quality of life (p=0.324; p>0.05). In conclusion, no significant relationship was found between medication beliefs and quality of life among hypertensive patients at Ngemplak Public Health Center, Boyolali, in 2026, within the study population overall. Further research should examine other factors, including therapy type, adverse drug reactions, medication adherence, and family support.